Ocular Therapeutix Inc (OCUL) — Cash Flow-to-Debt Ratio
Ocular Therapeutix Inc (OCUL) has a Cash Flow-to-Debt Ratio of -0.44x as of June 2026, meaning its operating cash flow of $-67.27 Million could theoretically repay 0% of its total liabilities ($151.28 Million) in one year. See Ocular Therapeutix Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ocular Therapeutix Inc Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Ocular Therapeutix Inc across 14 annual periods. For the full cash flow conversion analysis, see Ocular Therapeutix Inc operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Ocular Therapeutix Inc (2012–2025)
Year-by-year debt coverage analysis for Ocular Therapeutix Inc. Check how high is Ocular Therapeutix Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.33x | $-204.88 Million | $153.75 Million | ▼ -41.1% |
| 2024 | -0.94x | $-134.68 Million | $142.59 Million | ▼ -116.4% |
| 2023 | -0.44x | $-70.23 Million | $160.93 Million | ▲ +16.6% |
| 2022 | -0.52x | $-59.60 Million | $113.91 Million | ▲ +6.7% |
| 2021 | -0.56x | $-65.55 Million | $116.89 Million | ▼ -94.5% |
| 2020 | -0.29x | $-53.55 Million | $185.77 Million | ▲ +69.4% |
| 2019 | -0.94x | $-77.58 Million | $82.37 Million | ▲ +28.9% |
| 2018 | -1.32x | $-49.23 Million | $37.17 Million | ▲ +23.2% |
| 2017 | -1.72x | $-50.47 Million | $29.28 Million | ▼ -16.2% |
| 2016 | -1.48x | $-34.00 Million | $22.93 Million | ▲ +9.0% |
| 2015 | -1.63x | $-33.74 Million | $20.72 Million | ▼ -54.9% |
| 2014 | -1.05x | $-20.50 Million | $19.50 Million | ▼ -553.6% |
| 2013 | -0.16x | $-12.64 Million | $78.62 Million | ▲ +8.1% |
| 2012 | -0.18x | $-12.59 Million | $71.90 Million | — |